drug and placebo effects in depression additive[J].Biol Psychiatry，2000，47(2);99
[2]Thase ME，Entsuah AR，Rudolph RL. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors[J].Br J Psychiatry，2001，178(3)：234
[3]Thase ME，Haight BR，Richard N，et al.Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors：a metaanalysis of original data from 7 randomized controlled trials[J].J Clin Psychiatry，2005，66(6)：974
[4]Elkin I，Shea MT，Watkins JT，et al.National Institute of Mental Health Treatment of Depression Collaborative Research Program.General effectiveness of treatments[J].Arch Gen Psychiatry，1989，46(6)：971
[5]Dimidjian S，Hollon SD，Dobson KS，et al.Randomized trial of behavioral activation，cognitive therapy，and antidepressant medication in the acute treatment of adults with major depression[J].J Consult Clin Psychol，2006，74(4)：658
[6]DeRubeis RJ，Hollon SD，Amsterdam JD，et al. Cognitive therapy vs medications in the treatment of moderate to severe depression[J].Arch Gen Psychiatry，2005，62(3)：409
[7]Jarrett RB，Schaffer M，McIntire D，et al.Treatment of atypical depression with cognitive therapy or phenelzine：a doubleblind，placebocontrolled trial[J].Arch Gen Psychiatry，1999，56(3)：431
[8]Murphy GE，Simons AD，Wetzel RD，et al.Cognitive therapy and pharmacotherapy.Singly and together in the treatment of depression[J].Arch Gen Psychiatry，1984，41(1)：33
[9]Frank E，Kupfer DJ，Perel JM，et al.Threeyear outcomes for maintenance therapies in recurrent depression[J]. Arch Gen Psychiatry，1990，47(7)：1093
[10]Walsh BT，Seidman SN，Sysko R，Gould M.Placebo response in studies of major depression: variable，substantial，and growing[J].JAMA，2002，287(9)：1840
[11]Thase ME.How should efficacy be evaluated in randomized clinical trials of treatments for depression[J].J Clin Psychiatry，1999，60(Suppl 4)：S23
[12]Khan A，Schwart
上一页 [1] [2] [3] [4] 下一页
您现在的位置： 绿色健康网 >> 医学论文 >> 药学论文 >> 正文